Showing posts with label specialty. Show all posts
Showing posts with label specialty. Show all posts

Tuesday, October 13, 2020

New Drug Channels Institute Study Examines Impact of COVID-19 on U.S. Drug Distribution Industry - PRweb

According to the press release:

"Today Drug Channels Institute (DCI), a leading management educator for and about the pharmaceutical industry, released its exclusive analysis of U.S. prescription drug distribution channels. DCI’s new 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors delves into the business operations of the Big Three public drug wholesalers—AmerisourceBergen, Cardinal Health, and McKesson. Three new sections address COVID-19 and its impact on wholesalers, including the potential financial effects on wholesalers of widespread distribution of one or more COVID-19 vaccines."

Read the source press release:  New Drug Channels Institute Study Examines Impact of COVID-19 on U.S. Drug Distribution Industry - PRweb

View the free report overview:  The 2020-21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors - Overview (PDF)

Return Home:  The Designated Representative and Exemptee Blog

------

California Board of Pharmacy Designated Representative Training - by SkillsPlus International Inc. - for wholesalers, 3PL, reverse distributors. State Board Approved.

- - -

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Wednesday, November 12, 2014

Major Medical Centers ask Congress to Probe Genentech Distribution Shift - Pharmalot - WSJ

Read the full article: Major Medical Centers ask Congress to Probe Genentech Distribution Shift - Pharmalot - WSJ:

"Last month, Genentech angered hospitals and academic medical centers around the country by changing distribution for three big-selling cancer medicines. The drug maker is now using a handful of specialty distributors, which are actually divisions of the same wholesalers that have already been distributing Avastin, Rituxan and Herceptin. Until recently, dozens of wholesalers stocked the drugs."

'via Blog this'

Return Home:  The Designated Representative and Exemptee Blog

- - -

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Thursday, October 2, 2014

Genentech's distribution change for cancer drugs upsets hospitals | Modern Healthcare


Read the full article: Genentech's distribution change for cancer drugs upsets hospitals | Modern Healthcare:

"Drugmaker Genentech is changing the way it ships three high-profile cancer drugs to hospitals, which are concerned that the new process will grossly inflate their already high costs and potentially affect patient care. Genentech contends the change is designed to ensure patient safety and access to the drugs involved.

In a Sept. 16 letter to hospital pharmacy directors (PDF), Genentech, a U.S. subsidiary of Swiss healthcare giant Roche, said effective Oct. 1, hospitals can receive Avastin, Herceptin and Rituxan only through six authorized specialty distributors. The approved companies are ASD Healthcare, BioSolutionsDirect, Cardinal Health Specialty Distribution, McKesson Plasma and Biologics, Morris & Dickson Specialty Distribution and Smith Medical Partners.

For hospitals, this means they will have to contract with one of those specialty distributors if they want to continue receiving those three cancer drugs. Previously, hospitals purchased the drugs through wholesale distributors, which offer hospitals discounts based on purchase volume."

'via Blog this'

Return Home:  The Designated Representative and Exemptee Blog

Wednesday, March 26, 2014

HDMA survey of specialty distribution: Sales to physicians' offices have dropped by 66% - Pharmaceutical Commerce

HDMA survey of specialty distribution: sales to physicians' offices have dropped by 66% - Pharmaceutical Commerce:

"A recap helps explain: Specialty pharmaceuticals differ from traditional pharma products in that they tend to be “high touch”—needing numerous ancillary services such as infusion, monitored dispensing, REMS, or followup care. As they tend to be expensive, the reimbursement / prior authorization / patient-support questions are also complex. Oncology products, in particular, have traditionally been purchased under a “buy and bill” model by physicians’ practices, but this is fading (as the HDMA date show) in place of sales to specialty pharmacies and health systems."

'via Blog this'

Return Home:  The Designated Representative and Exemptee Blog

- - -

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Tuesday, September 3, 2013

Drug Channels: 12 Fastest-Growing, Private Specialty Pharmacies


Drug Channels: Say Hello to the 12 Fastest-Growing, Private Specialty Pharmacies:

"The 2013 Inc. 500 list, which is based on 2012 revenues, includes 12 specialty pharmacies. The pharmacies and their key stats are listed below, along with recent specialty forecasts. Diplomat Pharmacy again topped the specialty pharmacy list, with revenues of $1.1 billion, up 42% vs. 2011. The other 11 pharmacies had total revenues of $1.3 billion.

Pay attention: these companies are the vanguard of tomorrow’s pharmacy industry."

Return Home:  The Designated Representative and Exemptee Blog

For Designated Representative license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training affidavit):
     Florida:

For HMDR Exemptee license applicants  -  Training programs, courses, classes, seminars:

     California (earn a training completion certificate):

Custom Search

From SkillsPlus International Inc.